Mymetics to Advance Preclinical Studies for Virosome-based COVID-19 Vaccine through Innosuisse Grant

November 18, 2020 3:00 AM

Mymetics continues to progress its Covid-19 vaccine development plan based on its virosome-vaccine platform. Mymetics, through its collaborator, the Department of Pneumology at the Inselspital, Bern University Hospital, in Switzerland, have received a grant from the Swiss Innovation Agency (Innosuisse) to investigate Mymetics' intranasal Covid-19 vaccine candidates in preclinical studies. This new study will complement...

Read more

American Screening LLC Offers Comprehensive Choice of Urine and Saliva Drug Tests

November 17, 2020 9:10 PM

SHREVEPORT, LA / ACCESSWIRE / November 17, 2020 / For close to 17 years, American Screening LLC has been supporting efforts to combat substance abuse and addiction by providing a vast array of drug testing products and striving to offer the best possible prices without compromising on quality. This has helped the Shreveport, Louisiana-based company become an ISO13485 contract manufacturer and one of the leading distributors of diagnostic...

Read more

New Biotech Product From Merion Helps To Increase Metabolism and Support Anti-Aging

November 17, 2020 1:00 PM

NMN+++ product contains powerful NMN nucleotide LOS ANGELES, CA / ACCESSWIRE / November 17, 2020 / A new biotech product from Merion Inc. (OTCQB:EWLU) can help to increase metabolism, repair DNA and support anti-aging. The NMN+++ product contains the key ingredient nicotinamide mononucleotide (NMN). Scientists from the University of New South Wales and Harvard University have found that NMN can transform the bodily age indicators of...

Read more

BioLargo Revenue Continues Breaking Records as Water Technologies Ready for Commercialization

November 16, 2020 6:30 PM

Technology Portfolio Expanding WESTMINSTER, CA / ACCESSWIRE / November 16, 2020 / BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, filed with the SEC its Quarterly Report on Form 10-Q for the period ended September 30, 2020 (www.biolargo.com/sec-filings). BioLargo's Third Quarter Accomplishments Record revenue - generated record revenues in the third...

Read more

Citizen Stash Launches New Line of Cannabis Edibles

November 16, 2020 8:45 AM

VANCOUVER, BC / ACCESSWIRE / November 16, 2020 / Experion Holdings Ltd. (the "Corporation" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce it has now produced and shipped its first cannabis edible under its nationally recognized Citizen Stash brand. Designed for the legal adult recreational market Experion's initial shipment of its edible gummies product line will be directed first to...

Read more

Tetra Bio-Pharma Provides Update on Recent Milestones

November 16, 2020 6:30 AM

Plenitude Trial initiated Tetra completes clinical study assessing the metabolism profile of cannabinoids in humans Achieved development of ARDS-003 sterile injectable nano-emulsion for human use OTTAWA, ON / ACCESSWIRE / November 16, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today provided an...

Read more

PDS Biotech to Present at the Virtual Fall Investor Summit on November 16th-18th

November 13, 2020 3:00 PM

NEW YORK, NY / ACCESSWIRE / November 13, 2020 / PDS Biotechnology Corporation (NASDAQ:PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company's proprietary Versamune® T-cell activating technology, today announced that Dr. Frank Bedu-Addo, Chief Executive Officer, will be presenting at this year's virtual Fall Investor Summit taking place November...

Read more

Applied UV Announces Closing of $7,360,000 Public Offering Including Full Exercise of Overallotment Option

November 13, 2020 10:35 AM

MOUNT VERNON, NY / ACCESSWIRE / November 13, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced today's closing of its public offering of 1,401,905 shares of its common stock at a price of $5.25 per share...

Read more

Enzolytics Inc. Shares Current BioClonetics Immunotherapeutics, Inc. Update

November 13, 2020 9:00 AM

PLANO, TX / ACCESSWIRE / November 13, 2020 / Enzolytics Inc. (OTC PINK:ENZC) or the "Company" today shared the following update provided by ENZC's Merger target BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics"), resulting from the application of proceeds from the initial funding received on October 26, 2020. The full text of the update is presented below. November 13, 2020 Dear Investors and...

Read more

Xenetic Biosciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Corporate Update

November 13, 2020 8:00 AM

- Continued Advancement of XCART™ Platform Towards an IND Filing and Phase 1 Study - Leveraging Partnerships With Leading Global Academic Institutions, Including Scripps Research FRAMINGHAM, MA / ACCESSWIRE / November 13, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology...

Read more

Dyadic Announces Third Quarter 2020 Financial Results and Highlights Recent Company Progress

November 12, 2020 4:30 PM

Six new and expanded animal and human health collaborations since Q2 2020Expanded presence in the Asia Pacific RegionImportant progress and expanded animal efficacy data in COVID-19 vaccine and antibody programsZAPI to conduct additional animal studies for Schmallenberg Virus (SBV) and initiate animal studies for Rift Valley Fever Virus (RVFV)Continued strong financial position at end of third quarterJUPITER, FL / ACCESSWIRE / November 12, 2020...

Read more

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2020

November 12, 2020 4:30 PM

HILLSIDE, NJ / ACCESSWIRE / November 12, 2020 / Integrated BioPharma, Inc. (OTCQB:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2020. Revenue for the quarter ended September 30, 2020 was $15.2 million compared to $11.4 million for the quarter ended September 30, 2019, an increase of $3.8 million or 33.0%. The Company had operating income for the quarter ended September...

Read more

MustGrow Biologics Corp to Present at the virtual Fall Investor Summit on November 16th-18th

November 12, 2020 9:50 AM

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / MustGrow Biologics Corp (OTCQB:MGROF), an agriculture bio-tech company focused on providing natural, science-based biological solutions to replace synthetic chemicals, will be presenting at this year's virtual Fall Investor Summit on November 16th-18th. The Fall Investor Summit will take place virtually, featuring 75 companies and over 300 institutional and retail investors. About...

Read more

Khiron Life Sciences Corp. to Present at the virtual Fall Investor Summit on November 16th-18th

November 12, 2020 9:35 AM

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Khiron Life Sciences Corp. ((TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt:A2JMZC)), a vertically integrated cannabis leader with core operations in Latin America and Europe, will be presenting at this year's virtual Fall Investor Summit on November 16th-18th. The Fall Investor Summit will take place virtually, featuring 75 companies and over 300 institutional and retail investors. About Khiron Life...

Read more

ENDRA Life Sciences Inc. to Present at the virtual Fall Investor Summit on November 16th-18th

November 12, 2020 8:00 AM

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), The pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), will be presenting at this year's virtual Fall Investor Summit on November 16th-18th. The Fall Investor Summit will take place virtually, featuring 75 companies and over 300 institutional and retail investors. About ENDRA Life Sciences Inc. ENDRA Life Sciences Inc....

Read more

Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab

November 11, 2020 4:20 PM

MONROVIA, CA, PLANEGG/MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / November 11, 2020 / Xencor (XNCR), MorphoSys AG (FSE:MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ:MOR) and Incyte (INCY) today announced a clinical collaboration to investigate the combination of tafasitamab, plamotamab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), first-line DLBCL, and relapsed or refractory...

Read more

Milestone Scientific to Present at the Virtual Fall Investor Summit on November 18th

November 11, 2020 8:30 AM

ROSELAND, NJ / ACCESSWIRE / November 11, 2020 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at the Virtual Fall Investor Summit to be held virtually on November 16-18, 2020. Leonard Osser, Interim Chief Executive Officer, is scheduled to present on Wednesday, November 18th at 9:30 a.m., Eastern Time....

Read more

American Screening Corporation Provides Extensive Range of Home Drug Testing Products

November 11, 2020 5:30 AM

SHREVEPORT, LA / ACCESSWIRE / November 11, 2020 / American Screening Corporation (ASC) began as an enterprise with a mission to provide high-quality drug and alcohol testing products. Over the years, the company has grown into a premier domestic and international ISO13485 contract manufacturer and distributor of diagnostic tests and essential medical supplies while also expanding its mission to support the fight against drug addiction and mental...

Read more

Applied UV, Inc. Announces Pricing of $6.4 Million Underwritten Public Offering

November 10, 2020 9:25 AM

MOUNT VERNON, NY / ACCESSWIRE / November 10, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the pricing of its underwritten public offering of 1,219,048 shares of its common stock at a price of $5.25 per share....

Read more

EV Biologics is Targeting Pink Current

November 10, 2020 8:30 AM

CHEYENNE, WY / ACCESSWIRE / November 10, 2020 / EV Biologics Corp (OTC PINK:YECO) today announced that it has completed all its filings on OTC Markets and is now current in its reporting showing a Yield sign. The Company targeted to become current in its reporting before the end of October and is pleased to have achieved its goal within the announced time frame. Being current now allows the majority of brokers to trade in our shares, whereas...

Read more